Document Classification

Section Type: METHODS

Text: patients were randomized to receive : (a) gemcitabine 1000 mg/m (2) on days 1, 8 and 15 plus ifosfamide 1500 mg/m (2) on days 8-12 with mesna uroprotection (GI regimen) followed by vinorelbine 25 mg/m (2) on days 1 and 8 plus cisplatin 100 mg/m (2) on day 1 (GI -- > VC regimen) ; (b) the opposite sequence (VC -- > GI) ; (c) vinorelbine plus cisplatin as above described (VC regimen) ; or (d) gemcitabine 1400 mg/m (2) on days 1 and 8 plus cisplatin 100 mg/m (2) on day 8 (GC regimen).